Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Ingredion | INGR | 8. jan 2025 | 133.51 | +0.60 |
Inhibikase Therapeutics | IKT | 8. jan 2025 | 3.10 | -3.43 |
Inhibrx Biosciences | INBX | 8. jan 2025 | 14.98 | -3.42 |
INLIF LIMITED - ordinary shares | INLF | 8. jan 2025 | 4.62 | 0.00 |
InMed Pharmaceuticals | INM | 8. jan 2025 | 4.51 | -5.85 |
InMode | INMD | 8. jan 2025 | 16.01 | -7.99 |
INmune Bio | INMB | 8. jan 2025 | 5.30 | -4.85 |
Innate Pharma ADR | IPHA | 8. jan 2025 | 1.83 | -1.61 |
Inno Holdings | INHD | 8. jan 2025 | 4.95 | -1.98 |
Innodata | INOD | 8. jan 2025 | 36.76 | -5.98 |
Innospec | IOSP | 8. jan 2025 | 106.62 | +0.07 |
InnovAge | INNV | 8. jan 2025 | 3.78 | +2.44 |
Innovate | VATE | 8. jan 2025 | 5.40 | -3.57 |
Innovation Beverage Group | IBG | 8. jan 2025 | 0.98 | -4.41 |
Innovative Eyewear | LUCY | 8. jan 2025 | 5.68 | -9.27 |
Innovative Industrial Properties | IIPR | 8. jan 2025 | 65.44 | -1.45 |
Innovative Industrial Properties A Pref | IIPR-A | 8. jan 2025 | 25.01 | +0.04 |
Innovative Solutions and Support | ISSC | 8. jan 2025 | 8.50 | -0.23 |
Innovex International | INVX | 8. jan 2025 | 15.08 | -3.52 |
Innovid | CTV | 8. jan 2025 | 3.03 | 0.00 |
Innoviva | INVA | 8. jan 2025 | 17.31 | +0.17 |
Innoviz Technologies | INVZ | 8. jan 2025 | 1.88 | -14.55 |
InnSuites Hospitality | IHT | 8. jan 2025 | 2.62 | +1.07 |
Innventure | INV | 8. jan 2025 | 11.69 | -7.66 |
Inogen | INGN | 8. jan 2025 | 9.72 | +3.74 |
Inotiv | NOTV | 8. jan 2025 | 4.53 | -10.47 |
Inovio Pharmaceuticals | INO | 8. jan 2025 | 2.09 | -8.33 |
Inozyme Pharma | INZY | 8. jan 2025 | 2.80 | -0.71 |
Inpixon | XTIA | 8. jan 2025 | 0.05 | -55.74 |
InPoint Commercial Real Estate Pref A | ICR-A | 8. jan 2025 | 18.99 | -1.09 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.